表观基因组特征揭示孤独症谱系障碍的机制线索与预测标志物
本文综述表观遗传学(尤其是DNA甲基化)在孤独症谱系障碍(ASD)病因学中的研究进展。利用人脑及替代组织(胎盘、脐血)的表观全基因组关联研究发现了与ASD相关的趋同基因,部分与已知遗传风险因素重叠。表观基因组特征为ASD的早期预测、预防及药物靶点提供了线索,单细胞多组学与机器学习等技术有望推动其向精准公共卫生转化。
要点
- 胎盘和脐血DNA甲基化特征可反映胎儿脑基因转录、转录因子结合及染色质的既往差异。
- 综合征型与特发性ASD中双价染色质及部分趋同基因通路存在一致的表观遗传改变。
- NHIP的发现提示产前维生素使用可修饰ASD的常见遗传风险。
核心结论
- 表观基因组特征为ASD的早期预测、预防及药物干预靶点提供了有前景的线索。
研究设计与样本
- 综述类文章,未报告系统检索范围;总结近二十年DNA甲基化等表观遗传研究及表观全基因组关联研究。
主要发现
- 人脑与替代组织表观全基因组关联研究揭示了一些在ASD中表观遗传改变的趋同基因,许多与已知遗传风险因素重叠。
- 胎盘表观全基因组关联研究发现的NHIP提示ASD常见遗传风险受产前维生素使用修饰。
- 不同遗传综合征型ASD的表观基因组特征各异,但双价染色质和部分趋同基因通路在综合征型与特发性ASD及某些环境暴露中一致改变。
临床怎么用
- 胎盘和脐血等替代组织的DNA甲基化特征可用于追溯胎儿脑基因转录与染色质状态的既往差异。
- 表观基因组标志物有望用于ASD的早期预测与预防,并指导药物干预靶点的选择。
- 产前维生素使用可能修饰NHIP相关的ASD遗传风险,提示围产期干预的潜在价值。
局限性
- 本文为综述,未报告系统检索策略与纳入排除标准。
- 原文未报告具体样本量、效应值、阈值或统计显著性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autism spectrum disorder (ASD) comprises a heterogeneous group of neurodevelopmental outcomes in children with a commonality in deficits in social communication and language combined with repetitive behaviors and interests. The etiology of ASD is heterogeneous, as several hundred genes have been implicated as well as multiple in utero environmental exposures. Over the past two decades, epigenetic investigations, including DNA methylation, have emerged as a novel way to capture the complex interface of multivariate ASD etiologies. More recently, epigenome-wide association studies using human brain and surrogate accessible tissues have revealed some convergent genes that are epigenetically altered in ASD, many of which overlap with known genetic risk factors. Unlike transcriptomes, epigenomic signatures defined by DNA methylation from surrogate tissues such as placenta and cord blood can reflect past differences in fetal brain gene transcription, transcription factor binding, and chromatin. For example, the discovery of NHIP (neuronal hypoxia inducible, placenta associated) through an epigenome-wide association in placenta, identified a common genetic risk for ASD that was modified by prenatal vitamin use. While epigenomic signatures are distinct between different genetic syndromic causes of ASD, bivalent chromatin and some convergent gene pathways are consistently epigenetically altered in both syndromic and idiopathic ASD, as well as some environmental exposures. Together, these epigenomic signatures hold promising clues towards improved early prediction and prevention of ASD as well genes and gene pathways to target for pharmacological interventions. Future advancements in single cell and multi-omic technologies, machine learning, as well as non-invasive screening of epigenomic signatures during pregnancy or newborn periods are expected to continue to impact the translatability of the recent discoveries in epigenomics to precision public health.
引用
- LaSalle JM. Epigenomic signatures reveal mechanistic clues and predictive markers for autism spectrum disorder. Mol Psychiatry. 2023. PMID: 36650278. doi:10.1038/s41380-022-01917-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。